Vitamin K antagonists remain the INVICTUS standard of care for patients with rheumatic heart disease and atrial fibrillation

被引：0
作者：
Liuzzo, Giovanna [1 ,2 ]
Patrono, Carlo [3 ]
机构：
[1] Fdn Policlin Univ A Gemelli IRCCS, Dept Cardiovasc Med, Largo A Gemelli 8, I-00168 Rome, Italy
[2] Catholic Univ, Sch Med, Cardiovasc & Pulm Sci, Largo F Vito 1, I-00168 Rome, Italy
[3] Catholic Univ, Pharmacol, Sch Med, Largo F Vito 1, I-00168 Rome, Italy
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷 / 06期
关键词：
EFFICACY; REGISTRY; SAFETY;
D O I：
10.1093/eurheartj/ehac721
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：443 / 444
页数：2
相关论文
共 50 条
  • [41] Non-vitamin K antagonist oral anticoagulants in cancer patients with atrial fibrillation
    Undas, Anetta
    Drabik, Leszek
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2020, 23 (01) : 10 - 18
  • [42] Are low doses of non-vitamin K antagonists effective in Chinese patients with atrial fibrillation? A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry
    Kotalczyk, Agnieszka
    Guo, Yutao
    Wang, Yutang
    Lip, Gregory Y. H.
    INTERNATIONAL JOURNAL OF STROKE, 2022, 17 (08) : 848 - 854
  • [43] Evaluation of the anticoagulant effect of vitamin K antagonists in patients with non-valvular atrial fibrilation
    Stanojkovic, Zoran
    Antic, Ana
    Balint, Bela
    Todorovic, Milena
    Vucic, Miodrag
    Vacic, Nebojsa
    Lazarevic, Milan
    VOJNOSANITETSKI PREGLED, 2020, 77 (12) : 1260 - 1265
  • [44] Uninterrupted New Oral Anticoagulants Compared With Uninterrupted Vitamin K Antagonists in Ablation of Atrial Fibrillation: A Meta-analysis
    Nairooz, Ramez
    Ayoub, Karam
    Sardar, Partha
    Payne, Jason
    Almomani, Ahmed
    Pothineni, Naga Venkata
    Shailesh, Fnu
    Aronow, Wilbert S.
    Mukherjee, Debabrata
    CANADIAN JOURNAL OF CARDIOLOGY, 2016, 32 (06) : 814 - 823
  • [45] Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation
    Cappato, Riccardo
    Marchlinski, Francis E.
    Hohnloser, Stefan H.
    Naccarelli, Gerald V.
    Xiang, Jim
    Wilber, David J.
    Ma, Chang-Sheng
    Hess, Susanne
    Wells, Darryl S.
    Juang, George
    Vijgen, Johan
    Huegl, Burkhard J.
    Balasubramaniam, Richard
    De Chillou, Christian
    Davies, D. Wyn
    Fields, L. Eugene
    Natale, Andrea
    EUROPEAN HEART JOURNAL, 2015, 36 (28) : 1805 - 1811
  • [46] Ten years of non-vitamin K antagonists oral anticoagulants for stroke prevention in atrial fibrillation: is warfarin obsolete?
    Hammwoehner, Matthias
    Goette, Andreas
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0O) : 28 - 41
  • [47] Non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists in atrial fibrillation patients with previous stroke or intracranial hemorrhage: A systematic review and meta-analysis of observational studies
    Guo, Zongwen
    Ding, Xiaoli
    Ye, Zi
    Chen, Weiling
    Chen, Yijian
    CLINICAL CARDIOLOGY, 2021, 44 (07) : 917 - 924
  • [48] Novel anticoagulants versus vitamin K antagonists for cardioversion of non-valvular atrial fibrillation - a meta-analysis of more than 17000 patients
    Mincu, Raluca Ileana
    Mahabadi, Amir Abbas
    Totzeck, Matthias
    Rassaf, Tienush
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [49] The Risk of Gastrointestinal Bleeding between Non-Vitamin K Antagonist Oral Anticoagulants and Vitamin K Antagonists in the Asian Atrial Fibrillation Patients: A Meta-Analysis
    Yang, Kuang-Tsu
    Sun, Wei-Chih
    Tsai, Tzung-Jiun
    Tsay, Feng-Woei
    Chen, Wen-Chi
    Cheng, Jin-Shiung
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (01) : 1 - 16
  • [50] Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with vitamin K antagonists in patients with nonvalvular atrial fibrillation: a systematic literature review
    Briere, Jean-Baptiste
    Bowrin, Kevin
    Coleman, Craig
    Fauchier, Laurent
    Levy, Pierre
    Folkerts, Kerstin
    Toumi, Mondher
    Taieb, Vanessa
    Millier, Aurelie
    Wu, Olivia
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2019, 19 (01) : 27 - 36
12345